Website News and Research

RSS

Cephalon files definitive Consent Revocation Statement, recommends shareholders to reject Valeant's proposals

Cephalon, Inc. today announced that it has filed a definitive Consent Revocation Statement with the Securities and Exchange Commission (SEC) urging shareholders to reject Valeant Pharmaceuticals International Inc.'s proposals to remove Cephalon's entire Board of Directors and replace them with nominees hand-picked by Valeant.

22 Apr 2011

SAVE THE PATIENT hosts special community health show on CAN-TV

Celebrating its fifth year on CAN-TV, SAVE THE PATIENT is hosting a special community health show to reinforce the importance of positive, proactive and "preventative" interactions between patients and their health care resources—ranging from physicians to surgeons, nurses to advocates, pharmacists to educators, clinics to hospitals.

22 Apr 2011

Stanford and SanBio initiate SB623 Phase 1/2a clinical trial for stroke disability

The Stanford University School of Medicine and SanBio Inc. today announced the initiation of a Phase 1/2a clinical trial testing the safety and efficacy of a novel allogeneic cell therapy product, SB623, on patients suffering from stable deficits resulting from previous stroke injuries.

21 Apr 2011

NHATS to begin enrollment for study on improving quality of life among the elderly

21 Apr 2011

Enrollment begins in ‘National Health and Aging Trends’ study

The National Health and Aging Trends Study (NHATS), led by researchers at the Johns Hopkins Bloomberg School of Public Health, will begin enrolling study participants to examine how current and future aging populations can lead fuller, healthier lives. The study, which begins data collection on May 1, 2011, is supported by the National Institute on Aging and is designed to help researchers understand changes in health and functioning among seniors, as well as the social and economic consequences of health and aging for individuals, families and society.

20 Apr 2011

Blocking abnormal movement of mutated human FUS gene also blocks ALS process

In the first animal model of Amyotrophic Lateral Sclerosis (ALS), developed by Dr. Udai Pandey, Assistant Professor of Genetics at LSU Health Sciences Center New Orleans, Dr. Pandey's lab has found in fruit flies that blocking the abnormal movement of a protein made by a mutated gene called FUS also blocks the disease process.

20 Apr 2011

Furiex acquires full rights to JNJ-Q2, a novel broad-spectrum fluoroquinolone antibiotic

Furiex Pharmaceuticals, Inc. announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 under its existing development and license agreement with Janssen Pharmaceutica N.V.. Furiex acquired these rights as a result of Janssen's decision not to exercise its option under the agreement that gave Janssen the opportunity to continue development of JNJ-Q2.

20 Apr 2011

Diagnostic test Xpert MTB/RIF proven fast and effective in low-resource settings

The Lancet published a significant development for TB diagnostics yesterday with concrete and encouraging study outcomes on the effectiveness of the new Xpert MTB/RIF test for TB and rifampicin resistance in realistic health care field conditions. One of the authors, Prof. Mark Nicol of the University of Cape Town (South Africa) who contributed to this study, is an EDCTP Senior Fellow. The article demonstrates that the test can effectively be used in low-resource settings to simplify early and accurate diagnosis of patients. The potential impact is a reduction in the morbidity associated with diagnostic delay, dropout and mistreatment. The article has appeared online on 19 April 2011 and will be published in volume 377 on 30 April 2011.

20 Apr 2011

Biothera's Phase II clinical trials in lung cancer attain stage 1 endpoint

Biothera announced today that its second Phase II non-small cell lung cancer trial, evaluating Imprime PGG® in combination with bevacizumab (Avastin®) and two chemotherapeutic agents, has achieved its stage 1 endpoint and has begun enrolling patients for stage 2 of the study.

20 Apr 2011

DaVita re-designs its leading online kidney disease resource

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease and chronic kidney disease, today announced the redesign and launch of DaVita.com, the leading online resource for information about kidney disease.

19 Apr 2011

Medtronic introduces new Midas Rex e-Institute website

Medtronic, Inc. today announced the launch of its new Midas Rex e-Institute website, an enhanced web portal for healthcare professionals to explore interactive education on surgical anatomy, surgical procedures, and technical instruction.

19 Apr 2011

State Roundup: Mass. considers new health payment system

The California Public Employees' Retirement System is negotiating a lucrative pharmacy benefits management contract with Caremark Rx Inc., a company being sued for defrauding the pension fund of tens of millions of dollars (Lifsher, 4/16).

18 Apr 2011

True 2 Beauty launches new sexual enhancement supplements

True 2 Beauty Inc., a leading distributor of male and female sexual potency pills and liquid products in the United States, is pleased to announce the launch of a new, additional line of sexual enhancement supplements for men and women under the brand Blue Diamond and Pink Diamond.

18 Apr 2011

Consumers can trust the quality and value of heart-healthy imported olive oils: Study

Consumers can continue to trust the quality of the imported olive oils they buy in supermarkets throughout the United States, contrary to what the authors of a report funded by a small contingent of domestic olive oil producers would like them to believe.

16 Apr 2011

Study uses simulation model to assess cost-effective eye screenings for Americans with diabetes

Eye examinations every other year are more cost-effective than currently recommended annual eye exams for people with diabetes who are at low risk of diabetic retinopathy progression.

16 Apr 2011

Older workers benefit most from modest health behavior program

Older workers benefit most from a modest health behavior program when it combines a web-based risk assessment with personal coaching.

16 Apr 2011

Economists urge G20 finance ministers to support Tobin tax to fund global development

One thousand economists have signed a letter calling on G20 finance ministers, who are meeting in Washington this week, to support the "so-called 'Robin Hood tax' or Tobin tax on transactions in financial markets," the Guardian reports.

15 Apr 2011

Researchers report injectable gel can help treat arthritis

Some 25 million people in the United States alone suffer from rheumatoid arthritis or its cousin osteoarthritis, diseases characterized by often debilitating pain in the joints. Now researchers at Brigham and Women's Hospital report an injectable gel that could spell the future for treating these diseases and others.

15 Apr 2011

Active efforts towards happiness

Now the world's first membership organization dedicated to spreading happiness has been officially launched. It is called “Action for Happiness” and claims to have 4,500 members in more than 60 countries.

12 Apr 2011

First Edition: April 12, 2011

Today's headlines include details of what made up the short-term budget deal's $38 billion in cuts and how President Obama's longer term budget vision may take shape.

12 Apr 2011

Website News and Research

Cephalon files definitive Consent Revocation Statement, recommends shareholders to reject Valeant's proposals

SAVE THE PATIENT hosts special community health show on CAN-TV

Stanford and SanBio initiate SB623 Phase 1/2a clinical trial for stroke disability

NHATS to begin enrollment for study on improving quality of life among the elderly

Enrollment begins in ‘National Health and Aging Trends’ study

Blocking abnormal movement of mutated human FUS gene also blocks ALS process

Furiex acquires full rights to JNJ-Q2, a novel broad-spectrum fluoroquinolone antibiotic

Diagnostic test Xpert MTB/RIF proven fast and effective in low-resource settings

Biothera's Phase II clinical trials in lung cancer attain stage 1 endpoint

DaVita re-designs its leading online kidney disease resource

Medtronic introduces new Midas Rex e-Institute website

State Roundup: Mass. considers new health payment system

True 2 Beauty launches new sexual enhancement supplements

Consumers can trust the quality and value of heart-healthy imported olive oils: Study

Study uses simulation model to assess cost-effective eye screenings for Americans with diabetes

Older workers benefit most from modest health behavior program

Economists urge G20 finance ministers to support Tobin tax to fund global development

Researchers report injectable gel can help treat arthritis

Active efforts towards happiness

First Edition: April 12, 2011

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News